Chemours Co Q3 FY2026 earnings call

• Litigation Resolution: Reached a settlement with North Carolina and 11 local entities regarding PFAS claims at Fayetteville Works. Received final approval of the judicial consent order with New Jersey, establishing funding from MOU partners for decades-long settlement payments.
• Balance Sheet De-risking: Prioritized debt reduction, including an additional €50 million prepayment on Euro Term Loan B, bringing total annual debt reduction to €280 million. Completed the sale of the Quan Yin property parcel, realizing remaining proceeds.
• Operational Excellence: TSS managed the transition to lower GWP refrigerants under the U.S. STEAM Act, maintaining advantage with HVAC OEMs. TT executed consistent global pricing increases and optimized manufacturing circuits to match demand.
• Growth Initiatives: Launched the Phaseon product portfolio, a two-phase liquid cooling fluid targeting AI infrastructure data centers. APM Performance Solutions sales are approaching nearly half of the segment's revenue, driven by data center and semiconductor applications.
• Sustainability Progress: Reduced air and water process emissions of chlorinated organic chemicals by 80% since 2018, on track for 99%+ by 2030. Reduced Scope 1 and 2 greenhouse gas emissions by 57%, nearing the 60% target by 2030.

TSS (Titanium Solutions & Services): Net sales declined due to anticipated softness in the North American stationary AC aftermarket and lower demand for Opieon blends. Adjusted EBITDA was impacted by lower volumes and higher input costs, though long-term fundamentals remain strong. TT (TiO2 Technologies): Delivered earnings above the high end of guidance range driven by a 10% year-over-year increase in global pricing and disciplined commercial execution, offsetting weaker demand volumes in key regions like EMA and China. Approximately $5 million in earnings benefits were shifted from Q4 to Q3. APM (Advanced Performance Materials): Net sales grew significantly, supported by a 26% year-over-year increase in Performance Solutions sales. The business achieved meaningful improvements in earnings and margins due to a deliberate shift toward a higher-value portfolio mix and strong demand in AI infrastructure and semiconductor markets.

• TSS Q4 Outlook: Net sales expected to decline sequentially in the high teens to low 20% range due to seasonal patterns. Adjusted EBITDA guided between $105 million and $115 million.
• TT Q4 Outlook: Net sales expected to decline sequentially in the high single digits to low teens percentage range. Adjusted EBITDA guided between $60 million and $65 million, reflecting challenging end markets and timing impacts from Q3.
• APM Q4 Outlook: Net sales expected to increase sequentially in the low to mid-teens percentage range. Adjusted EBITDA guided between $40 million and $45 million.
• Full Year 2026 Outlook: Net sales growth expected around 2% compared to 2025. Adjusted EBITDA revised upward to be between $775 million and $800 million.
• Free Cash Flow: Conversion anticipated between 15% and 20%, lower than previous estimates due to litigation settlement payments, transaction taxes, and capex timing. Net leverage ratio expected below 4.2 times adjusted EBITDA at year-end 2026.
• 2027 Perspective: Management expects Chemours to deliver earnings growth in 2027 despite uncertain macroeconomic conditions, citing cost measures and operational improvements.

• Macroeconomic Uncertainty: Weakening demand across key end markets, including a consistently weak housing market and broader economic uncertainty affecting TT.
• Market Volatility: Anticipated softer demand in the North American stationary AC aftermarket for TSS in the near term.
• Regulatory and Trade Risks: Potential pressure from Chinese TiO2 imports flowing into the U.S. following anti-dumping duties in other regions; ongoing trade investigations and tariff implementations globally.
• Input Cost Fluctuations: Higher input costs, particularly sulfur, impacting TSS margins, although largely offset by pricing actions.
• Litigation Exposure: Legacy PFAS-related liabilities requiring significant settlement payments over decades, impacting cash flow and liquidity.

Q: Analyst asked about TSS input cost drivers and expectations for R32 pricing in China/India. / A: CEO Denise Dignam identified sulfur as the primary input cost increase but noted it has been overcome through pricing efforts. She stated no further changes in raw material inputs are expected and highlighted that Chinese producers have recently increased prices, supporting fair trade.